XML 41 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS' EQUITY
 9 Months Ended
Mar. 31, 2014
STOCKHOLDERS' EQUITY [Abstract]  
STOCKHOLDERS' EQUITY
NOTE 6: - STOCKHOLDERS' EQUITY
 
 
a.
From July 2013 through March 2014, a total of 2,244,574 warrants were exercised via "cashless" exercise, resulting in the issuance of 1,350,907 shares of common stock to investors of the Company.  In addition, 1,359,204 warrants were exercised for cash and resulted in the issuance of 1,359,204 shares of common stock to investors of the Company. The aggregate cash consideration received was $1,859. In August 2013, a total of 15,000 warrants were exercised via a "cashless" exercise, resulting in the issuance of 5,905 shares of common stock to a consultant of the Company. Additionally, 16,500 options were exercised by employees and consultants, resulting in an issuance of 16,500 shares of common stock.
 
 
b.
Following a shelf registration on Form S-3 filed and declared effective in October 2011, the Company entered in December 2012 into an At Market Issuance Sales Agreement ("ATM Agreement") with an underwriter, which provides that, upon the terms and subject to the conditions and limitations set forth in the ATM Agreement, the Company may elect, from time to time, to issue and sell shares of common stock having an aggregate offering price of up to $95,000 through the underwriter as a sales agent. The Company is not obligated to make any sales of common stock under the ATM Agreement.
During the three and nine months period ended March 31, 2014, the Company issued 2,433,786 shares of common stock and raised approximately $ 10,149, net of issuance expenses of $184, under the ATM Agreement.

 
c.
Options, warrants and restricted stock units to employees, directors and consultants:
 
 
1.
Options to employees and directors:
 
The Company has approved two incentive option plans from 2003 and from 2005 (collectively, the "Plans").

The Company accounted for its options to employees and directors in accordance with ASC 718, "Compensation - Stock Compensation". A summary of the Company's share option activity for options granted to employees and directors under the Plans is as follows:

   
Nine months ended March 31, 2014 (Unaudited)
  
   
Number
    
Weighted Average Exercise Price
    
Weighted Average Remaining Contractual Terms (in years)
    
Aggregate Intrinsic Value Price
  
Options outstanding at beginning of period
     1,958,156     $ 4.01              
Options exercised
     (15,000 )   $ 0.83              
Options forfeited
     (81,057 )   $ 11.59              
Options outstanding at end of the period
     1,862,099     $ 3.73       3.37     $ 1,461  
Options exercisable at the end of the period
     1,862,099     $ 3.73       3.37     $ 1,461  
Options vested
     1,862,099     $ 3.73       3.37     $ 1,461  

Intrinsic value of exercisable options (the difference between the Company's closing stock price on the last trading day in the period and the exercise price, multiplied by the number of in-the-money options) represents the amount that would have been received by the employees and directors option holders had all option holders exercised their options on March 31, 2014. This amount changes based on the fair market value of the Company's common stock.

 
2.
Options and warrants to non-employees:

A summary of the Company's activity related to options and warrants to consultants is as follows:

   
Nine months ended March 31, 2014 (Unaudited)
  
   
Number
    
Weighted Average Exercise Price
    
Weighted Average Remaining Contractual Terms (in years)
    
Aggregate Intrinsic Value Price
  
Options and warrants outstanding at beginning of period
     315,500     $ 4.40              
Options granted
     3,000     $ 0.00              
Options and warrants exercised
     (16,500 )   $ 1.74              
Options and warrants outstanding at end of the period
     302,000     $ 4.54       3.52     $ 535  
                                 
Options and warrants exercisable at the end of the period
     300,000     $ 4.54       3.45     $ 528  
                                 
Options and warrants vested and expected to vest
     302,000     $ 4.54       3.52     $ 535  
 
Compensation expenses related to options and warrants granted to consultants were recorded as follows:
 
   
Nine months ended March 31,
    
Three months ended March 31,
  
   
2014
    
2013
    
2014
    
2013
  
Research and development expenses
   $ 7     $ -     $ 7     $ -  
General and administrative expenses
     -       24       -       3  
    $ 7     $ 24     $ 7     $ 3  
 
 
3.
Restricted stock units to employees and directors:
 
During the nine month period ended March 31, 2014, the Company granted restricted stock units to several of the Company's employees and directors.
 
The following table summarizes the activities for unvested restricted stock units granted to employees and directors for the nine months ended March 31, 2014 (Unaudited):
 
   
Number
  
Unvested at the beginning of period
     1,660,525  
Granted
     1,224,908  
Forfeited
     (34,979 )
Vested
     (936,299 )
Unvested at the end of the period
     1,914,155  
Expected to vest after  March 31, 2014
     1,872,940  
 
Compensation expenses related to restricted stock units granted to employees and directors were recorded as follows:
 
   
Nine months ended March 31,
    
Three months ended March 31,
  
   
2014
    
2013
    
2014
    
2013
  
Research and development expenses
   $ 656     $ 573     $ 442     $ 92  
General and administrative expenses
     3,299       1,299       1,196       270  
    $ 3,955     $ 1,872     $ 1,638     $ 362  
 
Future expenses related to restricted stock units granted to employees and directors for an average time of approximately 2 years is $3,968.
 
 
4.
Restricted stock units to consultants:
 
During the nine month period ended March 31, 2014, the Company granted restricted stock units to several consultants and service providers.
 
The following table summarizes the activities for unvested restricted stock units granted to consultants for the nine months ended March 31, 2014:
 
   
Number
  
Unvested at the beginning of period
     -  
Granted
     71,460  
Forfeited
     -  
Vested
     (40,300 )
Unvested at the end of the period
     31,160  
Expected to vest after March 31, 2014
     31,160  
 
Compensation expenses related to restricted stock units granted to consultants were recorded as follows:
 
   
Nine months ended March 31,
    
Three months ended March 31,
  
   
2014
    
2013
    
2014
    
2013
  
Research and development expenses
   $ 59     $ 209     $ 42     $ 55  
General and administrative expenses
     157       278       157       -  
    $ 216     $ 487     $ 199     $ 55